Zai Lab Limited ADR’s filing revealed that its Director Chen Kai-Xian unloaded Company’s shares for reported $0.13 million on Jul 01 ’24. In the deal valued at $17.22 per share,7,750 shares were sold. As a result of this transaction, Chen Kai-Xian now holds 60,778 shares worth roughly $2.05 million.
Then, Amado Rafael sold 7,583 shares, generating $199,289 in total proceeds. Upon selling the shares at $26.28, the insider now owns 33,834 shares.
Before that, Amado Rafael bought 7,583 shares. Zai Lab Limited ADR shares valued at $199,287 were divested by the Officer at a price of $26.28 per share.
Morgan Stanley initiated its Zai Lab Limited ADR [ZLAB] rating to an Overweight in a research note published on December 14, 2023; the price target was $47.50. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early August with a ‘”an Overweight”‘ rating. Macquarie began covering ZLAB with “an Outperform” recommendation on January 21, 2022. Bernstein started covering the stock on October 12, 2021. It rated ZLAB as “a Mkt perform”.
Price Performance Review of ZLAB
On Friday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock jump 9.00% to $33.78. Over the last five days, the stock has gained 17.21%. Zai Lab Limited ADR shares have risen nearly 28.98% since the year began. Nevertheless, the stocks have risen 75.57% over the past one year. While a 52-week high of $36.60 was reached on 02/21/25, a 52-week low of $13.48 was recorded on 01/15/25. SMA at 50 days reached $26.98, while 200 days put it at $23.15.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 33.09, which if violated will result in even more drops to 32.41. On the upside, there is a resistance level at 34.73. A further resistance level may holdings at 35.69. The Relative Strength Index (RSI) on the 14-day chart is 79.95, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.10, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.66%. Stochastics %K at 76.01% indicates the stock is a holding.
The most recent change occurred on April 28, 2020 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating.
